Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules with enhanced metabolic stability and binding affinity. The trifluoromethyl group contributes to increased lipophilicity and electron-withdrawing effects, making this compound valuable in medicinal chemistry for optimizing drug candidates. It is also employed in the preparation of agrochemicals and specialty materials where fluorinated structures improve performance under harsh conditions. Its cyclic structure with a fluorinated substituent allows for stereoselective transformations, supporting its use in asymmetric synthesis and the creation of chiral building blocks.